The US Department of Justice (DOJ) announced a record recovery for fraud and false claims of US$5.69 billion for FY 2014. With recoveries amounting to more than of US$2.3 billion of the total recovery, healthcare remains the perennial heavyweight. This marks the fifth consecutive year that healthcare fraud recoveries have topped US$2 billion annually. The DOJ highlighted recoveries that cut a swath through the industry, including hospitals, home health providers, medical device makers, pharmacy providers and pharmaceutical companies.
This briefing highlights the details of this DOJ focus and other considerations that healthcare and life sciences clients should be concerned about in this regard.